Busulfex and cytomegalovirus viraemia 
Busulfex and cytomegalovirus viraemia Patient Reports February 13, 2012
Busulfex Side Effects Report #5743646-0
Busulfex side effect was reported by a Physician from JAPAN on May 08, 2008. Female patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute respiratory failure, anorexia, cytomegalovirus viraemia, diarrhoea, enterobacter sepsis, malaise, nausea
, renal failure acute, thrombocytopenia. Busulfex dosage: 24 ML. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5902789-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 17, 2008. Female patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal pain upper, acute respiratory failure, anorexia, blood bilirubin increased, bone marrow transplant
, bone marrow transplant rejection, cytomegalovirus viraemia, diarrhoea, enterobacter sepsis. Busulfex dosage: 24 ML, DAILY DOSE, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5800909-8
Busulfex side effect was reported by a Physician from JAPAN on June 20, 2008. Male patient, 64 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, atrial tachycardia, atrioventricular block, bone marrow transplant
, cytomegalovirus viraemia, diarrhoea, dysgeusia. Busulfex dosage: unknown. During the same period patient was treated with PHENYTOIN, NARTOGRASTIM, METHOTREXATE, TACROLIMUS, CYTARABINE, NOVANTRONE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5803065-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 24, 2008. Male patient, 63 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: bacterial sepsis, bifidobacterium infection, bronchopulmonary aspergillosis, candida sepsis, clostridium difficile colitis, cytomegalovirus viraemia, fungal sepsis, graft versus host disease, hyperbilirubinaemia. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE. Patient died on 10/06/2007.
Busulfex Side Effects Report #5743657-5
Busulfex side effect was reported by a Health Professional from JAPAN on May 08, 2008. Male patient, 60 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, anorexia, bone marrow transplant
, cytomegalovirus antigen positive, cytomegalovirus viraemia, graft versus host disease, liver disorder, nausea , nystagmus. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5812208-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 60 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, catheter related infection, cytomegalovirus viraemia, diarrhoea, enterocolitis bacterial, nausea
, stomatitis. Busulfex dosage: 31.48 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5849536-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 08, 2008. Female patient, 59 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, cytomegalovirus viraemia, diarrhoea, hypocalcaemia, malaise, platelet count decreased, renal failure acute. Busulfex dosage: 14 ML, DAILY DOSE INTRAVENOUS; 28 ML, DAILY DOSE; INTRAVENOUS; DAILY DOSE; INTRAVENOUS. During the same period patient was treated with PHENYTOIN, MELPHALAN, CYCLOSPORINE. Patient was hospitalized. Patient died on 09/07/2007.
Busulfex Side Effects Report #5894817-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 11, 2008. Male patient, 59 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, aspergillosis, cytomegalovirus viraemia, diarrhoea, interstitial lung disease, malaise, nausea
, oropharyngeal pain, pruritus. Busulfex dosage: 184 MG, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, FILGRASTIM. Patient died on 10/28/2007.Busulfex Side Effects Report #5698159-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: ascites, blister, blood bilirubin increased, bone marrow transplant
, cystitis haemorrhagic, cytomegalovirus viraemia, diarrhoea, graft versus host disease, haematochezia. Busulfex dosage: 31.72 ML, INTRAVENOUS. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5729833-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anaemia, anorexia, blast cell count increased, blood bilirubin increased, condition aggravated, cytomegalovirus viraemia, graft complication, haematemesis. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, TACROLIMUS, NEUPOGEN, VALPROATE, METHOTREXATE. Patient was hospitalized. Patient died on 05/01/2007.
Busulfex Side Effects Report #5893737-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, candida sepsis, cytomegalovirus viraemia, disseminated intravascular coagulation, histiocytosis haematophagic, nausea
, stem cell transplant, stomatitis. Busulfex dosage: 160 MG, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IMMUNOGLOBULIN, CYCLOSPORINE, METHOTREXATE, LEUCOVORIN CALCIUM, FILGRASTIM. Patient recovered.Busulfex Side Effects Report #5955102-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, candida sepsis, cytomegalovirus viraemia, disseminated intravascular coagulation, histiocytosis haematophagic, nausea
, stem cell transplant, stomatitis. Busulfex dosage: 160 MG, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, THYMOGLOBULIN, CYCLOSPORINE, FILGRASTIM, METHOTREXATE, LEUCOVORIN CALCIUM. Patient died.Busulfex Side Effects Report #5698164-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Male patient, 56 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, cystitis viral, cytomegalovirus antigen positive, cytomegalovirus viraemia, diarrhoea, enterococcal sepsis, hepatic function abnormal, nausea
. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, METHOTREXATE, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5955110-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: cytomegalovirus viraemia, diarrhoea, febrile neutropenia, hepatic function abnormal, hyperkalaemia, hyponatraemia, nausea
, renal impairment, stomatitis. Busulfex dosage: 8 ML, TID INTRAVENOUS; 8 ML, QID; INTRACAVERNOUS; 8 ML, QD; INTRAVENOUS. During the same period patient was treated with DEPAKENE, CYCLOPHOSPHAMIDE, NEUTROGIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5989585-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 20, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cytomegalovirus viraemia, diarrhoea, febrile neutropenia, hepatic function abnormal, hyperkalaemia, hyponatraemia, malaise, nausea
. Busulfex dosage: 8 ML, TID. During the same period patient was treated with DEPAKENE, CYCLOPHOSPHAMIDE, NEUTROGIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5984857-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 18, 2008. Female patient, 52 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: adult t-cell lymphoma/leukaemia recurrent, anorexia, bone marrow transplant
, cytomegalovirus viraemia, diarrhoea, hypokalaemia, malaise, nausea . Busulfex dosage: 6.4 ML, QD. During the same period patient was treated with DEPAKENE, FLUDARABINE PHOSPHATE, FILGRASTIM. Patient recovered.Busulfex Side Effects Report #5729827-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal pain
, acute graft versus host disease, cytomegalovirus viraemia, diarrhoea, febrile neutropenia, malaise, rash , stomatitis. Busulfex dosage: 24 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5798829-0
Busulfex side effect was reported by a Health Professional from JAPAN on June 16, 2008. Female patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, cytomegalovirus viraemia, enterocolitis, graft versus host disease, malaise, multi-organ failure, myelodysplastic syndrome. Busulfex dosage: 32 ML, INTRAVENOUS; 16 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5801805-2
Busulfex side effect was reported by a Physician from JAPAN on June 23, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: bone marrow transplant rejection, cytomegalovirus viraemia, diarrhoea, febrile neutropenia, graft versus host disease, hepatic pain, hypocalcaemia, hyponatraemia, malaise. Busulfex dosage: 24 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, NEUPOGEN, METHOTREXATE, TACROLIMUS, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5958872-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 04, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, cytomegalovirus viraemia, diarrhoea, hiccups, malaise, nausea
, neutropenia, oedema. Busulfex dosage: 8.2 ML, TID INTRAVENOUS; 8.2 ML, QID; INTRAVENOUS; 8.2 ML, QD; INTRAVENOUS. During the same period patient was treated with CYTARABINE, VALPROATE, CYCLOPHOSPHAMIDE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized and became disabled. Patient died.Busulfex Side Effects Report #6016185-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 09, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, bone marrow transplant
, cytomegalovirus viraemia, diarrhoea, hiccups, nausea , neutropenia, oedema, rash . Busulfex dosage: 8.2 ML, TID INTRAVENOUS : 8.2 ML,QID; INTRAVENOUS : 8.2 ML,QD;INTRAVENOUS. During the same period patient was treated with CYTARABINE, VALPROATE, CYCLOPHOSPHAMIDE, NARTOGRASTIM, TACROLIMUS. Patient was hospitalized and became disabled. Patient recovered.Busulfex Side Effects Report #6030744-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 25, 2008. Male patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant rejection, cellulitis
, cerebral haemorrhage, convulsion, cystitis haemorrhagic, cytomegalovirus viraemia, depressed level of consciousness. Busulfex dosage: 45 MG, QID INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, FILGRASTIM, METHOTREXATE. Patient died on 11/10/2007.Busulfex Side Effects Report #5767005-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on May 27, 2008. Male patient, 42 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cytomegalovirus viraemia, diarrhoea, encephalitis viral, febrile neutropenia, graft versus host disease, human herpesvirus 6 infection, nausea
, sepsis . Busulfex dosage: 36 ML. During the same period patient was treated with PHENYTOIN, NEUPOGEN, METHOTREXATE, TACROLIMUS, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient was hospitalized and became disabled. Patient recovered.Busulfex Side Effects Report #5839352-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 28, 2008. Male patient, 42 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, bone marrow transplant rejection, cytomegalovirus viraemia, diarrhoea, folliculitis, hepatic function abnormal, hyperamylasaemia, malaise, staphylococcal bacteraemia. Busulfex dosage: 20 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NARTOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5852711-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 07, 2008. Male patient, 34 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, adenoviral haemorrhagic cystitis, anorexia, ascites, bone marrow failure, bone marrow transplant
, candida sepsis, cytomegalovirus viraemia, diarrhoea. Busulfex dosage: 22.5 ML, INTRAVENOUS, 30 ML, DAILY DOSE; INTRAVENOUS, 7.5 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5809436-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2008. Female patient, 32 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, cystitis haemorrhagic, cytomegalovirus viraemia, diabetes mellitus, diarrhoea, escherichia sepsis, malaise, nausea
. Busulfex dosage: 22.5 ML, INTRAVENOUS; 9 ML; INTRAVENOUS; 36 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NEUPOGEN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5888697-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 31 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, adenoviral haemorrhagic cystitis, anorexia, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow transplant rejection, cytomegalovirus viraemia, diarrhoea, gamma-glutamyltransferase increased. Busulfex dosage: unknown. During the same period patient was treated with LENOGRASTIM, FOSCARNET, CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient died on 07/27/2007.
Busulfex Side Effects Report #5767273-4
Busulfex side effect was reported by a Health Professional from FRANCE on May 27, 2008. Female patient, 30 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: alopecia, anaemia, blood creatinine increased, blood lactate dehydrogenase increased, complications of bone marrow transplant, confusional state, cytomegalovirus viraemia, dysarthria, dyspnoea. Busulfex dosage: 16 ML, INTRAVENOUS. During the same period patient was treated with CYCLOSPORINE, CYCLOPHOSPHAMIDE, METHOTREXATE. Patient was hospitalized. Patient died.
Busulfex Side Effects Report #6015579-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 09, 2008. Female patient, 27 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, chest pain
, cytomegalovirus enterocolitis, cytomegalovirus viraemia, diarrhoea, febrile neutropenia, gamma-glutamyltransferase increased, haematocrit increased, headache . Busulfex dosage: 7.5 ML, TID 7.5 ML, QID 7.5 ML, QD. During the same period patient was treated with METHOTREXATE, ENDOXAN NET, FOSCAVIR, NEORAL, TACROLIMUS, LASIX. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5878628-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 26, 2008. Male patient, 17 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: bone marrow transplant
, bone marrow transplant rejection, cardiac failure, chronic graft versus host disease, cytomegalovirus viraemia, febrile neutropenia, fungal infection , pancreatitis, pneumonia staphylococcal. Busulfex dosage: 36 ML, INTRAVENOUS. During the same period patient was treated with TACROLIMUS, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOPHOSPAMIDE. Patient was hospitalized. Patient died on 08/20/2007.Busulfex Side Effects Report #5958873-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 06, 2008. Male patient, 16 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant
, bone marrow transplant rejection, cardiac failure, chronic graft versus host disease, cytomegalovirus viraemia, fungal infection , haemoglobin increased. Busulfex dosage: 36 ML, INTRAVENOUS. During the same period patient was treated with TACROLIMUS, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOPHOSPHAMIDE, LASIX. Patient was hospitalized. Patient died on 08/20/2007.Busulfex Side Effects Report #5819492-6
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: cardiac failure, cytomegalovirus chorioretinitis, cytomegalovirus viraemia, hypertrophic cardiomyopathy. Busulfex dosage: 1.88 ML INTRAVENOUS; 2.12 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient recovered.